Mast Cell Leukemia

specific

A progressive, proliferative disease of blood cells, originating from mast cells.

56

Centers

4

Active Trials

Cancer Funding

Top Centers for Mast Cell Leukemia(56)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.8
2
High-Volume Research Center
71.8
3
NCI Comprehensive
High-Volume Research Center
71.8
4
High-Volume Research Center
71.8
5
NCI Comprehensive
49.3
6
NCI Comprehensive
49.3
749.3
8
NCI Comprehensive
49.3
9
NCI Comprehensive
49.3
10
NCI Comprehensive
49.3
11
NCI Comprehensive
49.3
12
NCI Comprehensive
49.3
1349.3
1449.3
15
NCI Comprehensive
49.3
16
NCI Comprehensive
49.3
1749.3
1849.3
1949.3
20
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
49.3
21
NCI Comprehensive
49.3
22
NCI Comprehensive
49.3
2349.3
24
NCI Comprehensive
49.3
25
NCI Comprehensive
49.3
26
NCI Comprehensive
49.3
27
NCI Comprehensive
49.3
2849.3
29
NCI Comprehensive
49.3
3049.3
31
Cedars-Sinai CancerLos Angeles, CA
49.3
3249.3
3349.3
34
NCI Comprehensive
49.3
35
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
49.3
3649.3
3749.3
3849.3
3949.3
40
NCI Comprehensive
49.3
4149.3
4249.3
4349.3
4449.3
4549.3
4649.3
4749.3
4849.3
4949.3
5049.3
5149.3
5249.3
5349.3
5449.3
55
BC CancerVancouver, BC
49.3
5649.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →